Essay
Oral GLP-1 Agonists for Obesity and Diabetes
A guide to oral GLP-1 agonists, obesity and type 2 diabetes treatment, clinical promise, delivery advantages, and evidence still needed.
Contents
Topic hub
Search focus
oral GLP-1 agonists
Author
By Devin Teichrow. Published January 2, 2025.
Overview
A guide to oral GLP-1 agonists, obesity and type 2 diabetes treatment, clinical promise, delivery advantages, and evidence still needed.
Recently, a new wave of drugs has been developed that puts obesity and type 2 diabetes in a chokehold.
Read the full essay
https://theedgeofepidemiology.substack.com/p/oral-glp-1-agonists-show-major-promise
Archive note
This page keeps the essay connected to related topics, maps, and reference pages on The Edge of Epidemiology.